Change of Name

Recorded: 2024-08-02 Pages: 3

Assignor

VIVUS, INC.

Executed: 2021-07-08

Assignee

VIVUS LLC

900 E. HAMILTON AVE., SUITE 550, CAMPBELL, CALIFORNIA, 95008

Covered Property (1)

Orally Disintegrating Dosage Form for Administration of Avanafil, and Associated Methods of Manufacture and Use

Application: 18/788,497 →

Publication: US 2024/0382426

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.